MONDAY, Aug. 16 (HealthDay News) -- The ella (ulipristal acetate) emergency contraceptive has been approved by the U.S. Food and Drug Administration. It's been available in Europe for more than a year under the brand name ellaOne.
To be taken within five days of contraceptive failure or unprotected intercourse, the drug is not meant to be used as a routine contraceptive, according to the FDA. Ella's safety and effectiveness were demonstrated in studies conducted in the United States, United Kingdom, and Ireland. The most common side effects included headache, nausea, abdominal pain, menstrual pain, fatigue, and dizziness.
Women with known or suspected pregnancy or those who are breast-feeding shouldn't use ella, according to the FDA.
The drug is distributed by Watson Pharma Inc., based in Morristown, N.J.
The FDA has more about this approval.